Evidence map›Paper›PMID 38825048›Full record

ArticleGastroenterology2024

Enterocyte-Derived and Catalytically Active Transglutaminase 2 in the Gut Lumen of Mice: Implications for Celiac Disease.

Maureen T Meling, Liv Kleppa, Harrison A Besser, Chaitan Khosla, M Fleur du Pré, Ludvig M Sollid

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gastroenterology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maureen T MelingNorwegian Coeliac Disease Research Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway.
Liv KleppaNorwegian Coeliac Disease Research Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway.
Harrison A BesserDepartment of Chemistry, Stanford University, Stanford, California; Stanford Medical Scientist Training Program, Stanford University School of Medicine, Stanford, California.
Chaitan KhoslaDepartment of Chemistry, Stanford University, Stanford, California; Department of Chemical Engineering, Stanford University, Stanford, California; Sarafan ChEM-H, Stanford University, Stanford, California.
M Fleur du PréNorwegian Coeliac Disease Research Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway.
Ludvig M SollidNorwegian Coeliac Disease Research Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway. Electronic address: l.m.sollid@medisin.uio.no.

Funding

Localizing Pathogenically Relevant Transglutaminase 2 in Celiac DiseaseR01DK126487 · NIDDK · STANFORD UNIVERSITY · PI JABRI, BANA, KHOSLA, CHAITAN · 2021 to 2025
$1.8M
NIDDK NIH HHS R01 DK126487
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Celiac DiseaseEnterocytesGTP-Binding ProteinsProtein Glutamine gamma Glutamyltransferase 2TransglutaminasesAnimalsDisease Models, AnimalHumansIntestinal MucosaMiceMice, KnockoutGTP-Binding ProteinsProtein Glutamine gamma Glutamyltransferase 2Transglutaminases

Identifiers

PMID38825048
PMCPMC12087371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.